Orexo AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000736415
SEK
23.80
1.25 (5.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Cantargia AB
Oncopeptides AB
Egetis Therapeutics AB
Orexo AB
Xbrane Biopharma AB
Cereno Scientific AB
Xspray Pharma AB
SynAct Pharma AB
Infant Bacterial Therapeutics AB
FluoGuide A/S
Diamyd Medical AB

Why is Orexo AB ?

1
Negative results in Mar 26
  • NET SALES(Q) At SEK 5 MM has Fallen at -92.11%
  • PRE-TAX PROFIT(Q) At SEK -104.2 MM has Fallen at -53.07%
  • NET PROFIT(Q) At SEK -105.2 MM has Fallen at -52.57%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 20.81%, its profits have risen by 0.9%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Orexo AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Orexo AB
20.81%
0.14
59.34%
OMX Stockholm 30
30.13%
1.89
15.95%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-10.25%
EBIT Growth (5y)
-247.13%
EBIT to Interest (avg)
-5.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.24
Sales to Capital Employed (avg)
1.39
Tax Ratio
4.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.70
EV to EBIT
-2.85
EV to EBITDA
-5.29
EV to Capital Employed
5.98
EV to Sales
1.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-210.14%
ROE (Latest)
-40.99%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 106.8 MM

NET PROFIT(HY)

Higher at SEK -220.8 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 4.6 times

CASH AND EQV(HY)

Highest at SEK 1,298.6 MM

-28What is not working for the Company
NET SALES(Q)

At SEK 5 MM has Fallen at -92.11%

PRE-TAX PROFIT(Q)

At SEK -104.2 MM has Fallen at -53.07%

NET PROFIT(Q)

At SEK -105.2 MM has Fallen at -52.57%

RAW MATERIAL COST(Y)

Grown by 320.29% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.93 times

INTEREST(Q)

Highest at SEK 29.2 MM

OPERATING PROFIT(Q)

Lowest at SEK -74.2 MM

EPS(Q)

Lowest at SEK -3.81

Here's what is working for Orexo AB

Inventory Turnover Ratio
Highest at 4.6 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Cash Flow
Highest at SEK 106.8 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Cash and Eqv
Highest at SEK 1,298.6 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Orexo AB

Net Sales
At SEK 5 MM has Fallen at -92.11%
over average net sales of the previous four periods of SEK 63.35 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (SEK MM)

Pre-Tax Profit
At SEK -104.2 MM has Fallen at -53.07%
over average net sales of the previous four periods of SEK -68.08 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Net Profit
At SEK -105.2 MM has Fallen at -52.57%
over average net sales of the previous four periods of SEK -68.95 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (SEK MM)

Interest
At SEK 29.2 MM has Grown at 137.4%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest
Highest at SEK 29.2 MM
in the last five periods and Increased by 137.4% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Operating Profit
Lowest at SEK -74.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (SEK MM)

EPS
Lowest at SEK -3.81
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (SEK)

Debtors Turnover Ratio
Lowest at 1.93 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 320.29% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales